Screening for disease

American Journal of Roentgenology

Volumn 168, Issue 1, 1997, Pages 3-12

  Black, William C ^a,b   Welch, H Gilbert ^a,c  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER SCREENING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCREENING;

EID: 0031012393     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.168.1.8976910     Document Type: Review

References (80)

1. Morrison AS. Introduction. In: Screening in chronic disease, 2nd ed. New York: Oxford Univ. Press, 1992:3-20
2. Shapiro S, Venet W, Strax P, Venet L. Periodic screening for breast cancer: the Health Insurance Plan Project and its sequelae, 1963-1986. Baltimore: Johns Hopkins Univ. Press, 1988
3. United States Preventive Services Task Force. Guide to clinical preventive services, 2nd ed. Baltimore: Williams & Wilkins, 1996
4. Potterton AJ, Peakman DJ, Young JR. Ultrasound demonstration of small breast cancers detected by mammographic screening. Clin Radiol 1994;49: 808-813
5. Weinreb JC, Newstead G. MR imaging of the breast. Radiology 1995;196:593-610
6. Rice RP. Lowering the death rates from colorectal cancer: challenge for the 1990s. Radiology 1990;176:297-301
7. Marple JT, MacDougall M. Development of malignancy in the end-stage renal disease patient. Semin Nephrol 1993;13:306-314
8. Henschke C, Miettinen O, Yankelevitz DF, Libby DM, Smith JP. Radiographic screening for cancer: proposed paradigm for requisite research. Clin Imaging 1994;18:16-20
9. Hirata T, Tatars H, Zaizen Y, Suita S, Matsuzaki A, Ueda K. Role of ultrasound in managing neuroblastoma detected by mass screening: a proposed ultrasonographic grading for children with neuroblastoma. J Clin Ultrasound 1995;23:305-313
10. Taylor KJ, Schwanz PE. Screening for early ovarian cancer. Radiology 1994;192:1-10
11. Pollack HM, Resnick MI. Prostate-specific antigen and screening for prostate cancer: much ado about something? Radiology 1993;189:353-356
12. Russell JG. Is screening for abdominal aortic aneurysm worthwhile? Clin Radiol 1990;41:182-184
13. Tervonen O, Mueller DM, Maltesen EL, Velosa JA, Ginsburg WW, Ehman RL. Clinically occult avascular necrosis of the hip: prevalence in an asymptomatic population at risk. Radiology 1992;182:845-847
14. Derdeyn CP, Powers WJ, Moran CJ, Cross DT, Allen BT. Role of Doppler US in screening for carotid atherosclerotic disease. Radiology 1995; 197:635-643
15. Boyd DP. New horizons in cardiac imaging: screening for coronary artery disease using ultrafast computed tomography. Invest Radiol 1993;28[suppl 3]:S148
16. Lausen I, Jensen R, Wille-Jorgensen P, Jorgensen LN, Rasmussen MS, Lyng KM. Colour Doppler flow imaging ultrasonography versus venography as screening method for asymptomatic postoperative deep venous thrombosis. Eur J Radiol 1995; 20:200-204
17. United States Preventive Services Task Force. Screening ultrasonography in pregnancy. In: Guide to clinical preventive services, 2nd ed. Baltimoré: Williams & Wilkins, 1996:407-417
18. Black WC. Intracranial aneurysms in adult polycystic kidney disease: is screening with MRA indicated? Radiology 1994;191:18-20
19. Ronkainen A, Puranen MI, Hernesniemi JA, et al. Intracranial aneurysms: MR angiographic screening in 400 asymptomatic individuals with increased familial risk. Radiology 1995;195:35-40
20. Oshibuchi M, Nishi F, Sato M, Ohtake H, Okuda K. Frequency of abnormalities detected by abdominal ultrasound among Japanese adults. J Gastroenterol Hepatol 1991;6:165-168
21. Hubbell FA, Greenfield S, Tyler JL, Chetty K, Wyle FA. The impact of routine admission chest X-ray films on patient care. N Engl J Med 1985; 312:209-213
22. Tape TG, Mushlin AL. How useful are routine chest X-rays of preoperative patients at risk for postoperative chest disease? J Gen Intern Med 1988;3:15-20
23. United States Preventive Services Task Force. Screening for postmenopausal osteoporosis. In: Guide to clinical preventive services, 2nd ed. Baltimore: Williams & Wilkins, 1996:509-516
24. Sox HC, Blatt MA, Higgins MC, Marion KI. Selection and interpretation of diagnostic tests. In: Medical decision making, Boston: Butterworth-Heinemann, 1988:239-290
25. Verrilli D, Welch HG. The impact of diagnostic testing on therapeutic interventions. JAMA 1996; 275:1189-1191
26. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;12:1604-1608
27. Barsky AJ. The paradox of health. N Engl J Med 1988;318:414-418
28. Meador CK. The last well person. N Engl J Med 1994;330:440-441
29. Lee JM. Screening and informed consent. N Engl J Med 1993;328:438-440
30. Russell LB. Introduction. In: Educated guesses: making policy about medical screening tests. Berkeley, CA: Univ. of California Press, 1994:1-5
31. Morrison AS. The natural history of disease in relation to measures of disease frequency. In: Screening in chronic disease, 2nd ed. New York: Oxford Univ. Press, 1992:25-42
32. Morrison AS. Early detection: sensitivity and lead time. In: Screening in chronic disease, 2nd ed. New York: Oxford Univ. Press, 1992:57
33. Cole P, Morrison AS. Basic issues in population screening for patients. J Natl Cancer Inst 1980; 64:1263-1272
34. Nielsen M, Thomsen JL, Primdahl S. Dyreborg U, Andersen JA. Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer 1987;56:812-819
35. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson IC. Incidence of and treatment for ductal carcinoma in situ of the breast JAMA 1996; 275:913-918
36. Bosniak MA, Birnbaum BA, Krinsky GA, Waisman J. Small renal parenchyma] neoplasms: further observations on growth. Radiology 1995; 197:589-597
37. Black WC, Ling A. Is earlier diagnosis really better? The misleading effects of lead time and length biases. AJR 1990;155:625-630
38. Black WC, Welch HG. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med 1993;328:1237-1243
39. Sickles EA, Ominsky SH, Sollitto RA, Galvin HB, Monticciolo DL. Medical audit of a rapid- throughput mammography screening practice: methodology and results of 27,114 examinations. Radiology 1990;175:323-327
40. Begg CB, McNeil BJ. Assessment of radiologic tests: control of bias and other design considerations. Radiology 1988;167:565-569
41. Day NE, Williams DRR, Khaw KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 1989; 59:954-958
42. McNeil BJ, Keeler E, Adelstein SJ. Primer on certain elements of medical decision making. N Engl J Med 1975;293:211-215
43. Elmore JG, Wells CK, Lee CH, Howard DH, Feinstein AR. Variability in radiologist's interpretations of mammograms. N Engl J Med 1994; 331:1493-1499
44. Prorok PC, Hankey BF, Bundy BM. Concepts and problems in the evaluation of screening programs. J Chronic Dis 1981;34:159-171
45. Diehl LF, Perry DJ. A comparison of randomized concurrent control groups with matched historical control groups: are historical controls valid? J Clin Oncol 1986;4;1114-1120
46. Montie JE, Wood DP, Pontes E, et al. Adenocarcinoma of the prostate in cytoprostatectomy specimens removed for bladder cancer. Cancer 1989;63:381-385
47. Seidman H, Mushinski MH, Gelb SK, Silverberg BS. Probabilities of eventually developing or dying of cancer: United States, 1985. CA Cancer J Clin 1985;35:36-56
48. Sanderson DR. Lung cancer screening: the Mayo study. Chest 1986;89[suppl]:324S
49. Kramer BS, Gohagan J, Prorok PC, Smart C. A National Cancer Institute sponsored screening trial for prostatic. lung, colorectal, and ovarian cancers. Cancer 1993;71:589-593
50. Fletcher SW, Black WC, Harris R, Rimer BK, Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst 1993;85:1644-1656
51. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography: a meta-analysis. JAMA 1995;273:149-154
52. Tabar L, Fagerberg G, Duffey S, et al. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992;30:187-210
53. de Koning HJ, Boer R, Warmerdam PG, Beemsterboer PMM, van der Maas PJ. Quantitative interpretation of age-specific mortality reductions from the Swedish Breast Cancer-Screening Trials. J Natl Cancer Inst 1995;87:1217-1223
54. United States Preventive Services Task Force. Screening for lung cancer. In: Guide to clinical preventive services, 2nd ed. Baltimore: Williams & Wilkins, 1996:135-139
55. The GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: a multicenter randomized trial. JAMA 1994;271:1587-1593
56. Ewigman BG, Crane JP, Frigoletto FD, LeFevre ML, Bain RP, McNellis D. Effect of prenatal ultrasound screening on perinatal outcome: RADIUS Study Group. N Engl J Med 1993;329:821-827
57. Linver MN, Paster SB, Rosenberg RD, et al. Improvement in mammography interpretation skills in a community radiology practice after dedicated teaching courses: 2-year medical audit of 38,633 cases. Radiology 1992;184:39-43
58. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA 1995;273:548-552
59. Hennekens CH, Buring JE. Descriptive studies. In: Epidemiology in medicine. Boston: Little, Brown, 1987:101-131
60. Morrison AS. Cancer of the cervix. In: Screening in chronic disease, 2nd ed. New York: Oxford Univ. Press, 1992:216-233
61. Skrabanek P. Cervical cancer screening: the time for reappraisal. Can J Public Health 1988;79:86-89
62. Hennekens CH, Buring JE. Cohort studies. In: Epidemiology in medicine. Boston: Little, Brown, 1987:168-173
63. Morrison AS. Cancer of the breast. In: Screening in chronic disease, 2nd ed. New York: Oxford Univ. Press, 1992:186-200
64. Hennekens CH, Buring JE. Case-control studies. In: Epidemiology in medicine, Boston: Little, Brown, 1987:132-152
65. Hennekens CH, Buring JE. Measures of disease frequency and association. In: Epidemiology in medicine. Boston: Little, Brown, 1987:54-73
66. Hennekens CH, Buring JE. Intervention studies. In: Epidemiology in medicine. Boston: Little, Brown, 1987:178-212
67. Glasziou PP. Meta-analysis adjusting for compliance: the example of screening for breast cancer. J Clin Epidemiol 1992;45:1251-1256
68. Lachin JM. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials 1981;2:93-113
69. Laupacis A, Sacken DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988;318: 1728-1733
70. Mandel JS, Bond JH, Church T, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood: Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-1371
71. Barry MJ, Mulley AG, Fowler FJ, Wennberg JE. Watchful waiting vs immediate transurethral resection for symptomatic prostatism. JAMA 1988;259:3010-3017
72. Lerman C, Trock B, Rimer BK, Boyce A, Jepson C, Engstrom PF. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 1991;114:657-661
73. Wardle J, Pope R. The psychological costs of screening for cancer. J Psychosom Res 1992;36:609-624
74. Sullivan DC, Beam CA, Goodman SM, Watt DL. Measurement of force applied during mammography. Radiology 1991;181:353-357
75. Black WC, Nease RF, Tosteson ANA. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 1995;87:720-731
76. Nease RF, Tsai R, Hynes LH, Littenberg B. Automated utility assessment of global health. Qual Life Res 1996;5:175-182
77. Eddy DM. Screening for breast cancer. Ann Intern Med 1989;111:389-399
78. de Koning HJ, Ineveld BM, van Oortmarssen GJ, et al. Breast cancer screening and cost effectiveness: policy alternatives, quality of life considerations, and the possible impact of uncertain factors. Int J Cancer 1991;49:531-537
79. Black WC, Welch HG. A Markov model of early diagnosis. Acad Radiol 1996;3[suppl 1]:S10-S12
80. Black WC, Nease RF, Welch HG. Determining transition probabilities from mortality rates and autopsy findings. Med Decis Making (in press)